Towards Healthcare
Parkinson's Disease Diagnosis and Treatment Market Growth | Trends

Parkinson's Disease Diagnosis and Treatment Market Size Envisioned at USD 14.36 Billion by 2032

The report covers Parkinson's Disease Diagnosis and Treatment Market Companies and Segments involves employing imaging tests, blood tests, and other diagnostic procedures. Treatment options include medications such as Carbidopa-levodopa, Dopamine Agonists, MAO-B Inhibitors, COMT Inhibitors, Anticholinergics and other emerging therapies. Additionally, Deep Brain Stimulation and other treatment modalities offer alternatives for managing symptoms. Geographically, the market spans North America, Europe, Asia Pacific, Middle East and Africa, and South America. The report offers the value (in USD Billion) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value chain analysis
    • Raw material sourcing
    • Manufacturing process
    • Logistics & transportation
    • Buyer preferences
  • Trends
    • Market trends
    • Technological trends
  • Porter’s Five Forces Analysis
    • Bargaining power of suppliers
    • Bargaining power of buyers
    • Threat of substitute
    • Threat of new entrants
    • Degree of competition
  • PESTLE Analysis for 5 leading countries
    • Regulatory framework for leading countries/regions
    • Supply demand analysis
    • Production & consumption statistics
    • Export Import statistics
    • Price trend analysis

Global Parkinson's Disease Diagnosis and Treatment Market Assessment

  • Overview
  • Global Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
    • Imaging Tests
    • Blood Tests
    • Other Tests
  • Global Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Medications 
      • Carbidopa-levodopa
      • Dopamine Agonists
      • MAO-B Inhibitors
      • COMT Inhibitors
      • Anticholinergics
      • Others
    • Deep Brain Stimulation
    • Other Treatments
  • Global Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East & Africa (MEA)

North America Parkinson's Disease Diagnosis and Treatment Market Assessment

  • Overview
  • North America Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
    • Imaging Tests
    • Blood Tests
    • Other Tests
  • North America Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Medications 
      • Carbidopa-levodopa
      • Dopamine Agonists
      • MAO-B Inhibitors
      • COMT Inhibitors
      • Anticholinergics
      • Others
    • Deep Brain Stimulation
    • Other Treatments

Europe Parkinson's Disease Diagnosis and Treatment Market Assessment

  • Overview
  • Europe Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
    • Imaging Tests
    • Blood Tests
    • Other Tests
  • Europe Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Medications 
      • Carbidopa-levodopa
      • Dopamine Agonists
      • MAO-B Inhibitors
      • COMT Inhibitors
      • Anticholinergics
      • Others
    • Deep Brain Stimulation
    • Other Treatments

Asia Pacific Parkinson's Disease Diagnosis and Treatment Market Assessment

  • Overview
  • Asia Pacific Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
    • Imaging Tests
    • Blood Tests
    • Other Tests
  • Asia Pacific Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Medications 
      • Carbidopa-levodopa
      • Dopamine Agonists
      • MAO-B Inhibitors
      • COMT Inhibitors
      • Anticholinergics
      • Others
    • Deep Brain Stimulation
    • Other Treatments

Middle East and Africa Parkinson's Disease Diagnosis and Treatment Market Assessment

  • Overview
  • Middle East and Africa Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
    • Imaging Tests
    • Blood Tests
    • Other Tests
  • Middle East and Africa Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Medications 
      • Carbidopa-levodopa
      • Dopamine Agonists
      • MAO-B Inhibitors
      • COMT Inhibitors
      • Anticholinergics
      • Others
    • Deep Brain Stimulation
    • Other Treatments

South America Parkinson's Disease Diagnosis and Treatment Market Assessment

  • Overview
  • South America Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
    • Imaging Tests
    • Blood Tests
    • Other Tests
  • South America Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Medications 
      • Carbidopa-levodopa
      • Dopamine Agonists
      • MAO-B Inhibitors
      • COMT Inhibitors
      • Anticholinergics
      • Others
    • Deep Brain Stimulation
    • Other Treatments

Company Profiles

  • Siemens Healthineers AG
    • Company overview
    • Geographic footprints
    • Financial performance
    • Product portfolio
    • SWOT analysis
    • R&D efforts
    • Recent developments & strategic collaborations
      • Product launch/M&A/Technical collaboration
  • Abbott Laboratories
  • General Electric Company
  • AbbVie
  • Merck & Co.
  • Pfizer
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharma
  • Novartis AG
  • Cerevel Therapeutics

Conclusion & Recommendations

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.

FAQ's

Symptoms of Parkinsons disease include tremors, stiffness, slow movement, and problems with balance and coordination.

North America leads the market for Parkinsons disease diagnosis and treatment.

Deep Brain Stimulation (DBS) is a surgical procedure where electrodes are implanted into specific areas of the brain. These electrodes deliver electrical impulses to regulate abnormal brain activity, helping to alleviate symptoms of movement disorders like Parkinsons disease.

Department of Health, State Government of Victoria, Australia, U.S. Department of Veterans Affairs, National Institute of Health, WHO